7: Cognition, Mental Health & Substance Use, References

American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5), American Psychiatric Association, Arlington VA USA 2013

ASSIST (the Alcohol, Smoking and Substance Involvement Screening Test)
See www.who.int/publications/i/item/978924159938-2

Bourne A, Reid D, Hickson F et al. "Chemsex" and harm reduction need among gay men in South London. Int J Drug Policy.2015 Dec;26(12):1171-6.doi: 10.1016/j.drugpo.2015.07.013

Brandt C, Zvolensky MJ, Woods SP et al. Anxiety symptoms and disorders among adults living with HIV and AIDS: A critical review of and integrative synthesis of the empirical literature. Clin Psychol Rev. 2017;51:164-84 DOI:10.1016/j.cpr/2016.11.005

Coronado-Muñoz M, García-Cabrera E, Quintero-Flórez A et al. Sexualized Drug Use and Chemsex among Men Who Have Sex with Men in Europe: A Systematic Review and Meta-Analysis. J Clin Med. 2024 Mar 21;13(6):1812. doi: 10.3390/jcm13061812.

Freudenreich O, Goforth HW, Cozza K et al. Psychiatric Treatment of Persons with HIV/AIDS: An HIV-Psychiatry Consensus Survey of Current Practices. Psychosomatics. 2010; 51:480–8. DOI: 10.1016/S0033- 3182(10)70740-4

Garakani A, Murrough JW, Freire RC et al. Pharmacotherapy of Anxiety Disorders: Current and Emerging Treatment Options. Front Psychiatry. 2020; 11:595584 DOI: 10.3389/fpsyt.2020.595584

Generalized Anxiety Disorder - 2 Item Screening Tool (GAD-2) www.hiv.uw.edu/page/mental-health-screening/gad-2
This link provides details on the Generalized Anxiety Disorder 2-item (GAD- 2) screening tool for anxiety and validation details in persons with HIV

Humeniuk RE, Henry-Edwards S, Ali RL et al. The ASSIST-linked brief intervention for hazardous and harmful substance use: manual for use in primary care (2010). Geneva, World Health Organization.

Kroenke K, Spitzer RL, Williams JB et al. Anxiety disorders in primary care: prevalence, impairment, comorbidity, and detection. Ann Intern Med. 2007; 146:317-25 DOI:10.7326/0003-4819-146-5-200703060-00004

Nightingale S, Ances B, Cinque P et al. Cognitive impairment in people living with HIV: consensus recommendations for a new approach. Nat Rev Neurol. 2023 Jul;19(7):424-433. doi: 10.1038/s41582-023-00813-2

Spithoff S, Kahan M. Primary care management of alcohol use disorder and at-risk drinking: Part 1: screening and assessment. Can Fam Physician. 2015 Jun;61(6):509-14

Spithoff S, Kahan M. Primary care management of alcohol use disorder and at-risk drinking: Part 2: counsel, prescribe, connect. Can Fam Physician. 2015 Jun;61(6):515-21

Strong C, Huang P, Li CW et al. HIV, chemsex, and the need for harm-reduction interventions to support gay, bisexual, and other men who have sex with men. Lancet HIV. 2022 Oct;9(10):e717-e725. doi: 10.1016/S2352-3018(22)00124-2.

Stuart D. Chemsex: origins of the word, a history of the phenomenon and a respect to the culture. Drugs and Alcohol Today. January 2019;19(1).

Winston A, Antinori A, Cinque P, Fox HS, Gisslen M, Henrich TJ, Letendre S, Persaud D, Price RW, Spudich S. Defining cerebrospinal fluid HIV RNA escape: editorial review AIDS. AIDS. 2019 Dec 1;33 Suppl 2:S107-S111. doi: 10.1097/QAD.0000000000002252
This manuscript outlines the rationale for the consensus definition of cerebrospinal fluid HIV RNA escape which is utilised in the EACS Guidelines